Galectin Therapeutics
GALT
#9131
Rank
NZ$0.13 B
Marketcap
$2.21
Share price
-7.04%
Change (1 day)
-61.89%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$1.08

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.11. In 2022 the company made an earnings per share (EPS) of -$1.09 a decrease over its 2021 EPS that were of -$0.87.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.08-1.14%
2022-$1.0925%
2021-$0.8730%
2020-$0.67-6.98%
2019-$0.7213.16%
2018-$0.64-22.45%
2017-$0.82-35.53%
2016-$1.27-13.64%
2015-$1.4811.39%
2014-$1.32-39.69%
2013-$2.2081.94%
2012-$1.21-32.08%
2011-$1.787.07%
2010-$1.66-17.5%
2009-$2.01150%
2008-$0.80-68%
2007-$2.52127.27%
2006-$1.11-52.17%
2005-$2.31-20.69%
2004-$2.9252.63%
2003-$1.91-13.64%
2002-$2.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$21.50 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.32-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA